Clinical Trials for Ruxolitinib

1 Open Trial

Trial TypeProtocol No. &
Open Date
An Open Label Assessment of Safety and Efficacy of Ruxolitinib (INCB018424) in Subjects with Primary Myelofibrosis, Post Essential Thrombocythemia-Myelofibrosis and Post Polycythemia Vera-Myelofibrosis Who Have Platelet Counts of 50 X10 9/L to 100 X10 9/L

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.